Scinai Immunotherapeutics

About:

Scinai Immunotherapeutics is an innovative biopharmaceutical company.

Twitter/X: scinai_

Top Investors: RK Stone Miami, European Investment Bank, Office of the Chief Scientist

Description:

Scinai Immunotherapeutics is a biopharmaceutical company that focuses on research and development, manufacturing, and commercialization of innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases.

Total Funding Amount:

$87.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Ness Ziona, HaMerkaz, Israel

Founded Date:

2003-01-01

Contact Email:

info(AT)scinai.com

Founders:

Ron Babecoff

Number of Employees:

11-50

Last Funding Date:

2024-08-13

IPO Status:

Public

Industries: